Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

Proteomic studies of putative molecular signatures for biological effects by Korean Red Ginseng.

Lee YY, Seo HW, Kyung JS, Hyun SH, Han BC, Park S, So SH, Lee SH, Yi EC.

J Ginseng Res. 2019 Oct;43(4):666-675. doi: 10.1016/j.jgr.2019.05.001. Epub 2019 May 11.

2.

Correction to: Post-translational modification of OCT4 in breast cancer tumorigenesis.

Cho Y, Kang HG, Kim SJ, Lee S, Jee S, Ahn SG, Kang MJ, Song JS, Chung JY, Yi EC, Chun KH.

Cell Death Differ. 2019 Oct 22. doi: 10.1038/s41418-019-0439-x. [Epub ahead of print]

PMID:
31641242
3.

Refinements of LC-MS/MS Spectral Counting Statistics Improve Quantification of Low Abundance Proteins.

Lee HY, Kim EG, Jung HR, Jung JW, Kim HB, Cho JW, Kim KM, Yi EC.

Sci Rep. 2019 Sep 20;9(1):13653. doi: 10.1038/s41598-019-49665-1.

4.

Common Repository of FBS Proteins (cRFP) To Be Added to a Search Database for Mass Spectrometric Analysis of Cell Secretome.

Shin J, Kwon Y, Lee S, Na S, Hong EY, Ju S, Jung HG, Kaushal P, Shin S, Back JH, Choi SY, Kim EH, Lee SJ, Park YE, Ahn HS, Ahn Y, Kabir MH, Park SJ, Yang WS, Yeom J, Bang OY, Ha CW, Lee JW, Kang UB, Kim HJ, Park KS, Lee JE, Lee JE, Kim JY, Kim KP, Kim Y, Hirano H, Yi EC, Cho JY, Paek E, Lee C.

J Proteome Res. 2019 Oct 4;18(10):3800-3806. doi: 10.1021/acs.jproteome.9b00475. Epub 2019 Sep 10.

PMID:
31475827
5.

SEPROGADIC - serum protein-based gastric cancer prediction model for prognosis and selection of proper adjuvant therapy.

Ahn HS, Sohn TS, Kim MJ, Cho BK, Kim SM, Kim ST, Yi EC, Lee C.

Sci Rep. 2018 Nov 15;8(1):16892. doi: 10.1038/s41598-018-34858-x.

6.

The N-recognin UBR4 of the N-end rule pathway is required for neurogenesis and homeostasis of cell surface proteins.

Kim ST, Lee YJ, Tasaki T, Hwang J, Kang MJ, Yi EC, Kim BY, Kwon YT.

PLoS One. 2018 Aug 29;13(8):e0202260. doi: 10.1371/journal.pone.0202260. eCollection 2018.

7.

The N-recognin UBR4 of the N-end rule pathway is targeted to and required for the biogenesis of the early endosome.

Kim ST, Lee YJ, Tasaki T, Mun SR, Hwang J, Kang MJ, Ganipisetti S, Yi EC, Kim BY, Kwon YT.

J Cell Sci. 2018 Sep 10;131(17). pii: jcs217646. doi: 10.1242/jcs.217646.

8.

SRM-MS Method Development for Hepcidin-25 Peptide.

Cho KC, Cho BK, Jung JW, Lee YJ, Lee EB, Yi EC.

J Anal Methods Chem. 2018 Jun 14;2018:9653747. doi: 10.1155/2018/9653747. eCollection 2018.

9.

Apolipoprotein B binds to enolase-1 and aggravates inflammation in rheumatoid arthritis.

Lee JY, Kang MJ, Choi JY, Park JS, Park JK, Lee EY, Lee EB, Pap T, Yi EC, Song YW.

Ann Rheum Dis. 2018 Oct;77(10):1480-1489. doi: 10.1136/annrheumdis-2018-213444. Epub 2018 Jul 11.

PMID:
29997113
10.

Urinary vitamin D-binding protein, a novel biomarker for lupus nephritis, predicts the development of proteinuric flare.

Go DJ, Lee JY, Kang MJ, Lee EY, Lee EB, Yi EC, Song YW.

Lupus. 2018 Sep;27(10):1600-1615. doi: 10.1177/0961203318778774. Epub 2018 Jun 29.

PMID:
29958502
11.

Post-translational modification of OCT4 in breast cancer tumorigenesis.

Cho Y, Kang HG, Kim SJ, Lee S, Jee S, Ahn SG, Kang MJ, Song JS, Chung JY, Yi EC, Chun KH.

Cell Death Differ. 2018 Nov;25(10):1781-1795. doi: 10.1038/s41418-018-0079-6. Epub 2018 Mar 6. Erratum in: Cell Death Differ. 2019 Oct 22;:.

12.

A point mutation in the heavy chain complementarity-determining region 3 (HCDR3) significantly enhances the specificity of an anti-ROS1 antibody.

Lee HK, Jin J, Kim SI, Kang MJ, Yi EC, Kim JE, Park JB, Kim H, Chung J.

Biochem Biophys Res Commun. 2017 Nov 4;493(1):325-331. doi: 10.1016/j.bbrc.2017.09.023. Epub 2017 Sep 6.

PMID:
28888985
13.

Protein-Induced Pluripotent Stem Cells Ameliorate Cognitive Dysfunction and Reduce Aβ Deposition in a Mouse Model of Alzheimer's Disease.

Cha MY, Kwon YW, Ahn HS, Jeong H, Lee YY, Moon M, Baik SH, Kim DK, Song H, Yi EC, Hwang D, Kim HS, Mook-Jung I.

Stem Cells Transl Med. 2017 Jan;6(1):293-305. doi: 10.5966/sctm.2016-0081. Epub 2016 Aug 15.

14.

Identification of the nuclear localisation signal of O-GlcNAc transferase and its nuclear import regulation.

Seo HG, Kim HB, Kang MJ, Ryum JH, Yi EC, Cho JW.

Sci Rep. 2016 Oct 7;6:34614. doi: 10.1038/srep34614.

15.

Dynamic cohesin-mediated chromatin architecture controls epithelial-mesenchymal plasticity in cancer.

Yun J, Song SH, Kim HP, Han SW, Yi EC, Kim TY.

EMBO Rep. 2016 Sep;17(9):1343-59. doi: 10.15252/embr.201541852. Epub 2016 Jul 27.

16.

PiB-PET Imaging-Based Serum Proteome Profiles Predict Mild Cognitive Impairment and Alzheimer's Disease.

Kang S, Jeong H, Baek JH, Lee SJ, Han SH, Cho HJ, Kim H, Hong HS, Kim YH, Yi EC, Seo SW, Na DL, Hwang D, Mook-Jung I.

J Alzheimers Dis. 2016 Jul 6;53(4):1563-76. doi: 10.3233/JAD-160025.

PMID:
27392853
17.

Expression changes of proteins associated with the development of preeclampsia in maternal plasma: A case-control study.

Kim SM, Cho BK, Kang MJ, Norwitz ER, Lee SM, Lee J, Park CW, Kim BJ, Jun JK, Park JS, Yi EC.

Proteomics. 2016 May;16(10):1581-9. doi: 10.1002/pmic.201500381.

PMID:
27001287
18.

The Level of Autoantibodies Targeting Eukaryote Translation Elongation Factor 1 α1 and Ubiquitin-Conjugating Enzyme 2L3 in Nondiabetic Young Adults.

Kim EG, Kwak SH, Hwang D, Yi EC, Park KS, Koo BK, Kim KM.

Diabetes Metab J. 2016 Apr;40(2):154-60. doi: 10.4093/dmj.2016.40.2.154.

19.

Mitochondrial ATP synthase activity is impaired by suppressed O-GlcNAcylation in Alzheimer's disease.

Cha MY, Cho HJ, Kim C, Jung YO, Kang MJ, Murray ME, Hong HS, Choi YJ, Choi H, Kim DK, Choi H, Kim J, Dickson DW, Song HK, Cho JW, Yi EC, Kim J, Jin SM, Mook-Jung I.

Hum Mol Genet. 2015 Nov 15;24(22):6492-504. doi: 10.1093/hmg/ddv358. Epub 2015 Sep 10.

20.

Identification of a novel splice variant of neuronal nitric oxide synthase, nNOSβ, in myofilament fraction of murine cardiomyocytes.

Jang JH, Kang MJ, Ko GP, Kim SJ, Yi EC, Zhang YH.

Nitric Oxide. 2015 Nov 15;50:20-27. doi: 10.1016/j.niox.2015.07.005. Epub 2015 Aug 11.

PMID:
26271450
21.

Increased TRPC5 glutathionylation contributes to striatal neuron loss in Huntington's disease.

Hong C, Seo H, Kwak M, Jeon J, Jang J, Jeong EM, Myeong J, Hwang YJ, Ha K, Kang MJ, Lee KP, Yi EC, Kim IG, Jeon JH, Ryu H, So I.

Brain. 2015 Oct;138(Pt 10):3030-47. doi: 10.1093/brain/awv188. Epub 2015 Jun 30. Erratum in: Brain. 2016 Aug;139(Pt 8):e47.

22.

Ctbp2 Modulates NuRD-Mediated Deacetylation of H3K27 and Facilitates PRC2-Mediated H3K27me3 in Active Embryonic Stem Cell Genes During Exit from Pluripotency.

Kim TW, Kang BH, Jang H, Kwak S, Shin J, Kim H, Lee SE, Lee SM, Lee JH, Kim JH, Kim SY, Cho EJ, Kim JH, Park KS, Che JH, Han DW, Kang MJ, Yi EC, Youn HD.

Stem Cells. 2015 Aug;33(8):2442-55. doi: 10.1002/stem.2046. Epub 2015 May 26.

23.

Comparative proteomic profiling of pancreatic ductal adenocarcinoma cell lines.

Kim Y, Han D, Min H, Jin J, Yi EC, Kim Y.

Mol Cells. 2014 Dec 31;37(12):888-98. doi: 10.14348/molcells.2014.0207. Epub 2014 Dec 11.

24.

Heme-binding-mediated negative regulation of the tryptophan metabolic enzyme indoleamine 2,3-dioxygenase 1 (IDO1) by IDO2.

Lee YK, Lee HB, Shin DM, Kang MJ, Yi EC, Noh S, Lee J, Lee C, Min CK, Choi EY.

Exp Mol Med. 2014 Nov 14;46:e121. doi: 10.1038/emm.2014.69.

25.

Urinary proteome profile predictive of disease activity in rheumatoid arthritis.

Kang MJ, Park YJ, You S, Yoo SA, Choi S, Kim DH, Cho CS, Yi EC, Hwang D, Kim WU.

J Proteome Res. 2014 Nov 7;13(11):5206-17. doi: 10.1021/pr500467d. Epub 2014 Sep 15.

PMID:
25222917
26.

Identification of novel autoantibodies in type 1 diabetic patients using a high-density protein microarray.

Koo BK, Chae S, Kim KM, Kang MJ, Kim EG, Kwak SH, Jung HS, Cho YM, Choi SH, Park YJ, Shin CH, Jang HC, Shin CS, Hwang D, Yi EC, Park KS.

Diabetes. 2014 Sep;63(9):3022-32. doi: 10.2337/db13-1566. Epub 2014 Jun 19.

27.

Crucial role of calbindin-D28k in the pathogenesis of Alzheimer's disease mouse model.

Kook SY, Jeong H, Kang MJ, Park R, Shin HJ, Han SH, Son SM, Song H, Baik SH, Moon M, Yi EC, Hwang D, Mook-Jung I.

Cell Death Differ. 2014 Oct;21(10):1575-87. doi: 10.1038/cdd.2014.67. Epub 2014 May 23.

28.

Determination of selected reaction monitoring peptide transitions via multiplexed product-ion scan modes.

Cho BK, Koo YD, Kim K, Kang MJ, Lee YY, Kim Y, Park KS, Kim KP, Yi EC.

Rapid Commun Mass Spectrom. 2014 Apr 15;28(7):773-80. doi: 10.1002/rcm.6837.

PMID:
24573808
29.

Phosphoproteomic analysis identifies activated MET-axis PI3K/AKT and MAPK/ERK in lapatinib-resistant cancer cell line.

Lee YY, Kim HP, Kang MJ, Cho BK, Han SW, Kim TY, Yi EC.

Exp Mol Med. 2013 Nov 22;45:e64. doi: 10.1038/emm.2013.115.

30.

CD147 is critical for cancer stem cell chemoresistance: what does this mean for the clinic?

Kim KM, Yi EC.

Expert Rev Proteomics. 2013 Aug;10(4):313-5. doi: 10.1586/14789450.2013.814936. Review. No abstract available.

PMID:
23992413
31.

Reactive oxygen species regulate context-dependent inhibition of NFAT5 target genes.

Kim NH, Hong BK, Choi SY, Moo Kwon H, Cho CS, Yi EC, Kim WU.

Exp Mol Med. 2013 Jul 19;45:e32. doi: 10.1038/emm.2013.61.

32.

Synapsin-1 and tau reciprocal O-GlcNAcylation and phosphorylation sites in mouse brain synaptosomes.

Kang MJ, Kim C, Jeong H, Cho BK, Ryou AL, Hwang D, Mook-Jung I, Yi EC.

Exp Mol Med. 2013 Jun 28;45:e29. doi: 10.1038/emm.2013.56.

33.

Proteomic analysis reveals that CD147/EMMPRIN confers chemoresistance in cancer stem cell-like cells.

Kang MJ, Kim HP, Lee KS, Yoo YD, Kwon YT, Kim KM, Kim TY, Yi EC.

Proteomics. 2013 May;13(10-11):1714-25. doi: 10.1002/pmic.201200511. Epub 2013 Apr 23.

PMID:
23554123
34.

UBR box N-recognin-4 (UBR4), an N-recognin of the N-end rule pathway, and its role in yolk sac vascular development and autophagy.

Tasaki T, Kim ST, Zakrzewska A, Lee BE, Kang MJ, Yoo YD, Cha-Molstad HJ, Hwang J, Soung NK, Sung KS, Kim SH, Nguyen MD, Sun M, Yi EC, Kim BY, Kwon YT.

Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):3800-5. doi: 10.1073/pnas.1217358110. Epub 2013 Feb 19.

35.

Analysis of the biochemical role of Lys-11 in polyubiquitin chain formation using quantitative mass spectrometry.

Jung JW, Bae SJ, Kang GY, Kim KH, Yeo WS, Park SH, Seol JH, Yi EC, Kim KP.

Rapid Commun Mass Spectrom. 2013 Jan 30;27(2):339-46. doi: 10.1002/rcm.6447.

PMID:
23239382
36.

Heterodimerization of glycosylated insulin-like growth factor-1 receptors and insulin receptors in cancer cells sensitive to anti-IGF1R antibody.

Kim JG, Kang MJ, Yoon YK, Kim HP, Park J, Song SH, Han SW, Park JW, Kang GH, Kang KW, Oh DY, Im SA, Bang YJ, Yi EC, Kim TY.

PLoS One. 2012;7(3):e33322. doi: 10.1371/journal.pone.0033322. Epub 2012 Mar 16.

37.

Mapping protein receptor-ligand interactions via in vivo chemical crosslinking, affinity purification, and differential mass spectrometry.

Kim KM, Yi EC, Kim Y.

Methods. 2012 Feb;56(2):161-5. doi: 10.1016/j.ymeth.2011.10.013. Epub 2011 Oct 30.

PMID:
22062956
38.

The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans.

Brandt CS, Baratin M, Yi EC, Kennedy J, Gao Z, Fox B, Haldeman B, Ostrander CD, Kaifu T, Chabannon C, Moretta A, West R, Xu W, Vivier E, Levin SD.

J Exp Med. 2009 Jul 6;206(7):1495-503. doi: 10.1084/jem.20090681. Epub 2009 Jun 15.

39.

Quantitative protein profile comparisons using the isotope-coded affinity tag method.

Yi EC, Goodlett DR.

Curr Protoc Protein Sci. 2004 Feb;Chapter 23:Unit 23.2. doi: 10.1002/0471140864.ps2302s34.

PMID:
18429263
40.

Use of gas-phase fractionation to increase protein identifications : application to the peroxisome.

Kennedy J, Yi EC.

Methods Mol Biol. 2008;432:217-28. doi: 10.1007/978-1-59745-028-7_15.

PMID:
18370021
41.

Systematic uncovering of multiple pathways underlying the pathology of Huntington disease by an acid-cleavable isotope-coded affinity tag approach.

Chiang MC, Juo CG, Chang HH, Chen HM, Yi EC, Chern Y.

Mol Cell Proteomics. 2007 May;6(5):781-97. Epub 2007 Jan 31.

42.

Preparation and Use of an Integrated Microcapillary HPLC Column and ESI Device for Proteomic Analysis.

Goodlett DR, Yi EC, Mottay P.

CSH Protoc. 2007 May 1;2007:pdb.prot4617. doi: 10.1101/pdb.prot4617.

PMID:
21357072
43.

UniPep--a database for human N-linked glycosites: a resource for biomarker discovery.

Zhang H, Loriaux P, Eng J, Campbell D, Keller A, Moss P, Bonneau R, Zhang N, Zhou Y, Wollscheid B, Cooke K, Yi EC, Lee H, Peskind ER, Zhang J, Smith RD, Aebersold R.

Genome Biol. 2006;7(8):R73. Epub 2006 Aug 10.

44.

Quantitative proteomic profiling of pancreatic cancer juice.

Chen R, Pan S, Yi EC, Donohoe S, Bronner MP, Potter JD, Goodlett DR, Aebersold R, Brentnall TA.

Proteomics. 2006 Jul;6(13):3871-9.

PMID:
16739137
45.

Proteome analysis of Halobacterium sp. NRC-1 facilitated by the biomodule analysis tool BMSorter.

Gan RR, Yi EC, Chiu Y, Lee H, Kao YC, Wu TH, Aebersold R, Goodlett DR, Ng WV.

Mol Cell Proteomics. 2006 Jun;5(6):987-97. Epub 2006 Feb 23.

46.

The mobile nucleoporin Nup2p and chromatin-bound Prp20p function in endogenous NPC-mediated transcriptional control.

Dilworth DJ, Tackett AJ, Rogers RS, Yi EC, Christmas RH, Smith JJ, Siegel AF, Chait BT, Wozniak RW, Aitchison JD.

J Cell Biol. 2005 Dec 19;171(6):955-65.

47.

Improving mass and liquid chromatography based identification of proteins using bayesian scoring.

Chen SS, Deutsch EW, Yi EC, Li XJ, Goodlett DR, Aebersold R.

J Proteome Res. 2005 Nov-Dec;4(6):2174-84.

PMID:
16335964
48.
49.

Pancreatic cancer proteome: the proteins that underlie invasion, metastasis, and immunologic escape.

Chen R, Yi EC, Donohoe S, Pan S, Eng J, Cooke K, Crispin DA, Lane Z, Goodlett DR, Bronner MP, Aebersold R, Brentnall TA.

Gastroenterology. 2005 Oct;129(4):1187-97.

PMID:
16230073
50.

Human Plasma PeptideAtlas.

Deutsch EW, Eng JK, Zhang H, King NL, Nesvizhskii AI, Lin B, Lee H, Yi EC, Ossola R, Aebersold R.

Proteomics. 2005 Aug;5(13):3497-500.

PMID:
16052627

Supplemental Content

Support Center